Myasthenia gravis (MG) is a rare neuromuscular disease characterized by bodily weakness and exhaustion. It occurs when the connection between nerves and muscle tissue is impaired . This breakdown is typically due to immune factors attacking the meeting place where signals and the muscular system

Biktarvy functions as a groundbreaking medication designed to controlling HIV. This powerful combination therapy combines : emtricitabine, rilpivirine, and bictegravir. These components work synergistically to inhibit the replication of the HIV virus, thereby pausing disease progression. To numer